Natalizumab and Progressive Multifocal LeukoencephalopathyBurt Adelman, Michael Panzara, Alfred Sandrock|New England Journal of Medicine|2005Cited by 82
Bayesian adaptive design for clinical trials in Duchenne muscular dystrophyStephen Lake, Michael Panzara, Jennifer Panagoulias et al.|Statistics in Medicine|2021Cited by 12
EP.83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skippingKathryn R. Wagner, Michael Panzara, Linda Cripe et al.|Neuromuscular Disorders|2019Cited by 1